Caseware UK (AP4) 2024.0.164 2024.0.164 2025-03-312025-03-311falseThe members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.1No description of principal activity2024-04-01falsefalse SC568266 2024-04-01 2025-03-31 SC568266 2023-04-01 2024-03-31 SC568266 2025-03-31 SC568266 2024-03-31 SC568266 c:Director1 2024-04-01 2025-03-31 SC568266 d:CurrentFinancialInstruments 2025-03-31 SC568266 d:CurrentFinancialInstruments 2024-03-31 SC568266 c:Micro-entities 2024-04-01 2025-03-31 SC568266 c:AuditExempt-NoAccountantsReport 2024-04-01 2025-03-31 SC568266 c:FullAccounts 2024-04-01 2025-03-31 SC568266 c:PrivateLimitedCompanyLtd 2024-04-01 2025-03-31 SC568266 e:PoundSterling 2024-04-01 2025-03-31 iso4217:GBP xbrli:pure

Registered number: SC568266










CAESAR MEDICAL LIMITED








UNAUDITED

FINANCIAL STATEMENTS

INFORMATION FOR FILING WITH THE REGISTRAR

FOR THE YEAR ENDED 31 MARCH 2025

 
CAESAR MEDICAL LIMITED
REGISTERED NUMBER: SC568266

BALANCE SHEET
AS AT 31 MARCH 2025

2025
2024
£
£


Current assets
54,457
36,621

Creditors: amounts falling due within one year
(16,579)
(12,271)

Net current assets
 
 
37,878
 
 
24,350

Total assets less current liabilities
37,878
24,350


Net assets
37,878
24,350



Capital and reserves
37,878
24,350


Notes


General information

Caesar Medical Limited is a private company limited by shares incorporated in Scotland. The registered office is 6 St Colme Street, Edinburgh, EH3 6AD.


Average number of employees

The average monthly number of employees, including directors, during the year was 1 (2024 - 1).

The directors consider that the Company is entitled to exemption from audit under section 477 of the Companies Act 2006 and members have not required the Company to obtain an audit for the year in question in accordance with section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements.

These financial statements have been prepared in accordance with the provisions applicable to entities subject to the micro-entities' regime.

The financial statements have been delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The financial statements were approved and authorised for issue by the board and were signed on its behalf on 6 November 2025.




................................................
Dr Claire Grace Caesar
Director

 
Page 1